Attached files
| file | filename |
|---|---|
| EX-10.1 - Emergent BioSolutions Inc. | exhibit10_1.htm |
| EX-32 - Emergent BioSolutions Inc. | exhibit32_2.htm |
| EX-32 - Emergent BioSolutions Inc. | exhibit32_1.htm |
| EX-31 - Emergent BioSolutions Inc. | exhibit31_2.htm |
| EX-31 - Emergent BioSolutions Inc. | exhibit31_1.htm |
| EX-10.2 - Emergent BioSolutions Inc. | exhibit10_2.htm |
| 10-Q - Emergent BioSolutions Inc. | form10-q032018.htm |
EXHIBIT 12
|
Ratio of Earnings to Fixed Charges
|
|||||||||||||||||||||||
|
Year to Date
|
|||||||||||||||||||||||
|
|
March 31,
|
Year Ended December 31,
|
|||||||||||||||||||||
|
(in thousands)
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
|||||||||||||||||
|
|
|||||||||||||||||||||||
|
Pretax income (loss) from continuing operations (1)
|
$
|
(9,423)
|
|
$
|
118,633
|
$
|
99,221
|
$
|
135,716
|
$
|
84,194
|
$
|
83,439
|
||||||||||
|
Fixed charges
|
|||||||||||||||||||||||
|
Interest expense
|
211
|
6,987
|
8,270
|
7,834
|
7,480
|
1,973
|
|||||||||||||||||
|
Debt issuance cost
|
95
|
1,759
|
1,526
|
1,564
|
3,290
|
319
|
|||||||||||||||||
|
Total fixed charges (2)
|
306
|
8,746
|
9,796
|
9,398
|
10,770
|
2,292
|
|||||||||||||||||
|
Noncontrolling interest in pretax income (3)
|
-
|
-
|
-
|
-
|
-
|
876
|
|||||||||||||||||
|
Capitalized interest (4)
|
72
|
2,156
|
2,179
|
2,875
|
2,530
|
1,973
|
|||||||||||||||||
|
Earnings ((1) + (2) -(3) -(4))
|
(9,189)
|
|
125,223
|
106,838
|
142,239
|
92,434
|
82,882
|
||||||||||||||||
|
Fixed charges
|
306
|
8,746
|
9,796
|
9,398
|
10,770
|
2,292
|
|||||||||||||||||
|
Ratio of earnings to fixed charges
|
-
|
14.3
|
10.9
|
15.1
|
8.6
|
36.2
|
|||||||||||||||||
| Coverage deficiency | (9,423) | - | - | - | - | - | |||||||||||||||||